What is ChemPacific?
ChemPacific Corp operates as a sophisticated chemical manufacturing entity, bridging the gap between complex laboratory research and large-scale industrial production. The firm provides a comprehensive suite of services, including custom chemical synthesis, process development, and contract research. With a specialized focus on eco-friendly latex rubber emulsions, specialty intermediates, and active pharmaceutical ingredients (APIs), ChemPacific distinguishes itself through American-managed manufacturing standards. Their unique value proposition lies in their deep expertise within the Chinese marketplace, allowing them to support global clients throughout the entire product life cycle, from initial discovery to final commercial launch.
How much funding has ChemPacific raised?
ChemPacific has raised a total of $773K across 2 funding rounds:
Debt
$350K
Debt
$423K
Debt (2020): $350K with participation from PPP
Debt (2021): $423K led by PPP
Key Investors in ChemPacific
PPP
Public-Private Partnership
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for ChemPacific?
With this major enterprise-level funding, ChemPacific is positioned to accelerate its strategic initiatives, particularly in the expansion of its eco-friendly product lines and the optimization of its cross-border supply chain. The capital will likely be deployed to enhance process development capabilities and scale manufacturing capacity to meet the rising demand for high-purity APIs and specialty intermediates. As the company navigates the complexities of international chemical regulations and market volatility, this financial backing provides the necessary liquidity to maintain its competitive edge. Future growth will likely center on deepening its footprint in the pharmaceutical sector and refining its sustainable manufacturing processes to align with global environmental standards.
See full ChemPacific company page